NICHD maternal fetal medicine units network
NICHD母胎医学单位网
基本信息
- 批准号:10254471
- 负责人:
- 金额:$ 26.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-04-08 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAddressAdherenceAlloimmunizationAmbulatory Care FacilitiesAmericanBedsBioinformaticsBirthCOVID-19 pandemicCaringCesarean sectionChildCitiesClinicClinic VisitsClinicalClinical ResearchClinical TrialsCollaborationsComputerized Medical RecordDataData AnalysesData Coordinating CenterDepartment chairDiabetes MellitusDiscipline of obstetricsEnrollmentEnsureEnvironmentEpidemiologistFacultyFundingFunding OpportunitiesGoalsGrantHepatitis C TransmissionHepatitis C virusHospital AdministratorsHospitalizationHospitalsHumanHypertensionImageInfant MortalityInformation SystemsInfrastructureInstitutionInvestmentsLaboratoriesLeadershipLettersLinkMaternal-Fetal Medicine Units NetworkMaternal-fetal medicineMedical centerMissionMothersNational Heart, Lung, and Blood InstituteNational Institute of Child Health and Human DevelopmentNeonatalNeonatal Intensive Care UnitsNeonatologyNetwork-basedNotificationNulliparityNurse AdministratorNursesOhioOutpatientsParticipantPathologyPatientsPediatric HospitalsPerformancePerinatalPerinatal EpidemiologyPerinatal mortality demographicsPharmacologyPhysiciansPoliciesPopulationPopulation HeterogeneityPositioning AttributePostpartum PeriodPravastatinPre-EclampsiaPregnancy OutcomePregnancy in DiabeticsPremature BirthPrenatal carePreventionPrincipal InvestigatorProductivityProtocols documentationProviderPublicationsResearchResearch DesignResearch InfrastructureResearch PersonnelResourcesRiskServicesSiteStructureSystemTranslational ResearchTrial of LaborTrustU-Series Cooperative AgreementsUniversitiesVertical Disease TransmissionWomanantenatalbaseclinical careclinical centerclinical investigationcommunity involvementdata qualityethnic diversityexperiencefaculty researchfetalfollow-uphigh riskimprovedinfant morbidityinnovationintrapartummemberopioid use disorderprematureprenatalpreventprogramsprotocol developmentracial diversityrecruitresponsescreeningstatistics
项目摘要
ABSTRACT
This proposal describes the application of The Ohio State University (OSU) Center for continued participation
in the Eunice Kennedy Shriver NICHD Maternal Fetal Medicine Units (MFMU) Network. The current application
describes our team, environment and resources to meet the objectives of the Network. Since 1992, the OSU
Center has demonstrated a strong performance and experience in conducting clinical and translational
research based on excellent infrastructure and institutional support. We developed a strong research team led
by Maged Costantine, MD who was recruited to the OSU Wexner Medical Center in 2019, as a Division
Director for Maternal Fetal Medicine and Principal Investigator for the MFMU Network Center, and Mark
Landon, MD who serves as Chair for the Department of OG/GYN and Alternate PI. In addition to productivity in
the MFMU Network, both the PI and alternate PI, bring extensive experience in study design, recruitment, data
analysis, and publications. The OSU Network will recruit study participants from diverse populations at 3
medical centers with a combined total of more than 15,000 annual births, many of them are high-risk, and the
majority receiving prenatal care at the three systems. Our Center Nurse Coordinator, Anna Bartholomew,
MPH, RN, BSN, CCRP, leads a large group of faculty & research staff capable of recruiting and retaining
patients in the setting of an excellent research organization enhanced by 29 years of experience in the MFMU
Network, participation in the NICHD Nulliparous Network, and memberships in the North American Fetal
Treatment Network, and Ohio Perinatal Research Network (OPRN). We benefit from a robust bioinformatics
structure and versatile Electronic Medical Record System (EMR) that captures antepartum, intrapartum, and
postpartum data online and is readily available to authorized research personnel for query as well as automatic
notification, an extraordinary group of obstetrical sonographers, perinatal epidemiologists, and a mature
research infrastructure supported by a CTSA grant shared with Nationwide Children’s Hospital. Our satellite
sites, Miami Valley Hospital in Dayton and Good Samaritan Hospital in Cincinnati, have an outstanding record
of recruitment in the most recent Network cycle, well-established research culture, and ambitious goals for
MFMU Network participation. Our partnership and strong collaboration with Neonatology at Nationwide
Children’s Hospital in clinical care and research, Pathology and Clinical Laboratory add strengths to our
application. We look forward to continuing our tradition of service, strong performance, and innovation in the
next cycle of the NICHD MFMU Network. We accept the RFA’s capitation and participatory stipulations and
stand ready to achieve the goals of the Network in completion of the ongoing studies in a collaborative way
across all research centers.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maged Costantine其他文献
Maged Costantine的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maged Costantine', 18)}}的其他基金
Developing Extracellular Vesicle Based MPRINT Translational Resource Platform for Monitoring Therapeutics Response During Pregnancy
开发基于细胞外囊泡的 MPRINT 转化资源平台,用于监测妊娠期间的治疗反应
- 批准号:
10747545 - 财政年份:2023
- 资助金额:
$ 26.98万 - 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
- 批准号:
10087196 - 财政年份:2019
- 资助金额:
$ 26.98万 - 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
- 批准号:
10705607 - 财政年份:2019
- 资助金额:
$ 26.98万 - 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
- 批准号:
10162643 - 财政年份:2019
- 资助金额:
$ 26.98万 - 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
- 批准号:
10455106 - 财政年份:2019
- 资助金额:
$ 26.98万 - 项目类别:
Comprehensive evaluation of the safety and utility of pravastatin in prevention of preeclampsia in high-risk pregnant women
普伐他汀预防高危孕妇子痫前期的安全性和有效性综合评价
- 批准号:
9119186 - 财政年份:
- 资助金额:
$ 26.98万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 26.98万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 26.98万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 26.98万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 26.98万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 26.98万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 26.98万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 26.98万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 26.98万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 26.98万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 26.98万 - 项目类别:














{{item.name}}会员




